Medytox, Daewoong’s Botox Strain Dispute Set To Simmer Until Commission Decision
Executive Summary
The ongoing battle between Korea's Medytox and Daewoong Pharm over the source of the botulinum toxin strain in Daewoong’s product looks set to rumble on until a trade commission unveils the results of its probe next year.